Skip to main navigation

Main navigation

  • about
  • our approach
  • our pipeline
  • investors & media
  • join #onejounce
  • contact us

Main navigation

  • about
  • our approach
  • our pipeline
  • investors & media
  • join #onejounce
  • contact us
follow
contact
our media

Investors & Media

SEC Filing Details

Document Details

Form
10-K
Filing Date
Mar 6, 2019
Document Date
Dec 31, 2018
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Jounce Therapeutics, Inc.
Issuer
Jounce Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

IR menu

  • Investor Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • Publications
  • Financial Information
  • Annual Meeting
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

Shareholder Tools

  • Print Page
  • RSS Feeds
  • Contact IR

Pages

  • Home
  • About
  • Our Approach
  • Our Pipeline
  • Investors and Media
  • Join #OneJounce
  • Career Opportunities

Resources

  • Press Releases
  • ContactContact

Leadership

  • Management Team
  • Board of Directors
  • Company Founders

Focus

  • Pipeline Overview
  • T Cell Approach
  • Beyond T Cell

© Jounce Therapeutics, Inc. All rights reserved. | Privacy Policy | Terms of Use

Contact Us

Jounce Therapeutics, Inc.
780 Memorial Drive
Cambridge, MA 02139
Phone: (857) 259-3840
Fax: (888) 459-2940
For media inquiries, please contact:
Malin Deon
(857) 259-3843 or
mdeon@jouncetx.com

Mark Yore
(857) 200-1255 or
myore@jouncetx.com